Skip to main content

Table 8 Comparison between RECIST 1.1 and PERCIST 1.0-based therapeutic response assessment in the study population

From: Comparison between RECIST and PERCIST criteria in therapeutic response assessment in cases of lymphoma

 

Treatment response by RECIST 1.1

Test value*

P value

Sig

CR

PR

SD

PD

Total

Treatment response by PERCIST 1.0

CMR

8 (100.0%)

10 (55.6%)

0 (0%)

0 (0%)

18

46.139

0.00

HS

PMR

0 (0%)

7 (38.9%)

2 (66.7%)

0 (0%)

9

SMD

0 (0%)

1 (5.6%)

1 (33.3%)

0 (0%)

2

PMD

0 (0%)

0 (0%)

0 (0%)

4 (100%)

4

Total

8

18

3

4

33

  1. P value > 0.05 Non significant (NS), P value < 0.05 Significant (S), P value < 0.01 Highly significant (HS)
  2. *Chi-square test